DE69228738D1 - Zusammensetzungen zur Behandlung von entzündlichen Zuständen oder Analgesie, die Ranitidin Wismuth Citrat und einen NSAID enthalten - Google Patents

Zusammensetzungen zur Behandlung von entzündlichen Zuständen oder Analgesie, die Ranitidin Wismuth Citrat und einen NSAID enthalten

Info

Publication number
DE69228738D1
DE69228738D1 DE69228738T DE69228738T DE69228738D1 DE 69228738 D1 DE69228738 D1 DE 69228738D1 DE 69228738 T DE69228738 T DE 69228738T DE 69228738 T DE69228738 T DE 69228738T DE 69228738 D1 DE69228738 D1 DE 69228738D1
Authority
DE
Germany
Prior art keywords
nsaid
inflammatory
compositions containing
bismuth citrate
analgesic compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69228738T
Other languages
English (en)
Inventor
Roger Stables
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919126027A external-priority patent/GB9126027D0/en
Priority claimed from GB929206083A external-priority patent/GB9206083D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of DE69228738D1 publication Critical patent/DE69228738D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DE69228738T 1991-12-06 1992-11-27 Zusammensetzungen zur Behandlung von entzündlichen Zuständen oder Analgesie, die Ranitidin Wismuth Citrat und einen NSAID enthalten Expired - Lifetime DE69228738D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919126027A GB9126027D0 (en) 1991-12-06 1991-12-06 Medicaments
GB929206083A GB9206083D0 (en) 1992-03-20 1992-03-20 Medicaments

Publications (1)

Publication Number Publication Date
DE69228738D1 true DE69228738D1 (de) 1999-04-29

Family

ID=26299971

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69228738T Expired - Lifetime DE69228738D1 (de) 1991-12-06 1992-11-27 Zusammensetzungen zur Behandlung von entzündlichen Zuständen oder Analgesie, die Ranitidin Wismuth Citrat und einen NSAID enthalten

Country Status (26)

Country Link
US (1) US5466436A (de)
EP (1) EP0550083B1 (de)
JP (1) JPH05246853A (de)
KR (1) KR930009605A (de)
AP (1) AP324A (de)
AT (1) AT401468B (de)
AU (1) AU664574B2 (de)
BE (1) BE1007268A3 (de)
CA (1) CA2084568A1 (de)
CH (1) CH685537A5 (de)
CZ (1) CZ358092A3 (de)
DE (1) DE69228738D1 (de)
DK (1) DK0550083T3 (de)
ES (1) ES2130152T3 (de)
FR (1) FR2684554B1 (de)
GB (1) GB2262036B (de)
GR (1) GR3030426T3 (de)
IE (1) IE922866A1 (de)
IL (1) IL103978A (de)
IT (1) IT1256697B (de)
LU (1) LU88196A1 (de)
MX (1) MX9207008A (de)
MY (1) MY108146A (de)
NO (1) NO303670B1 (de)
NZ (1) NZ245365A (de)
PH (1) PH31380A (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9501560D0 (en) * 1995-01-26 1995-03-15 Nycomed Imaging As Contrast agents
JPH10512877A (ja) * 1995-01-26 1998-12-08 ニコムド イメージング エイ／エス ビスマス化合物
CA2271381A1 (en) * 1996-11-22 1998-05-28 Owen Rickford Carryl Compositions for the treatment of gastrointestinal disorders containing bismuth and nsaid
CA2271799A1 (en) * 1996-11-22 1998-05-28 The Procter & Gamble Company Compositions for the treatment of gastrointestinal disorders containing bismuth, and nsaid and one or more antimicrobials
SE0000773D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
SE0000774D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
JP2004520422A (ja) * 2001-03-08 2004-07-08 アストラゼネカ・アクチエボラーグ 新しい用途
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
EP1411900B2 (de) * 2001-06-01 2013-12-04 Pozen, Inc. Pharmazeutische zusammensetzungen für die koordinierte abgabe von nsaid
SE0102993D0 (sv) 2001-09-07 2001-09-07 Astrazeneca Ab New self emulsifying drug delivery system
US20080021078A1 (en) * 2006-07-18 2008-01-24 Horizon Therapeutics, Inc. Methods and medicaments for administration of ibuprofen
US20080020040A1 (en) * 2006-07-18 2008-01-24 Horizon Therapeutics, Inc. Unit dose form for administration of ibuprofen
US8067451B2 (en) * 2006-07-18 2011-11-29 Horizon Pharma Usa, Inc. Methods and medicaments for administration of ibuprofen
WO2007012022A2 (en) * 2005-07-18 2007-01-25 Horizon Therapeutics, Inc. Unit dose form with ibuprofen-famotidine admixture
US8067033B2 (en) 2007-11-30 2011-11-29 Horizon Pharma Usa, Inc. Stable compositions of famotidine and ibuprofen
US20100297224A1 (en) * 2006-08-31 2010-11-25 Horizon Therapeutics, Inc. NSAID Dose Unit Formulations with H2-Receptor Antagonists and Methods of Use
BRPI0918492A2 (pt) 2008-09-09 2015-12-01 Astrazeneca Ab uso de naproxen, ou sal farmaceuticamente aceitável do mesmo, e esomeprazol, ou sal farmaceuticamente aceitável do mesmo
SG176724A1 (en) 2009-06-25 2012-01-30 Astrazeneca Ab Method for treating a patient at risk for developing an nsaid-associated ulcer
US9539214B2 (en) 2011-12-28 2017-01-10 Pozen Inc. Compositions and methods for delivery of omeprazole plus acetylsalicylic acid
CN110893233A (zh) * 2019-12-19 2020-03-20 川北医学院附属医院 一种鸢尾素在制备抗炎药物中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464679A (en) * 1981-07-06 1984-08-07 Rca Corporation Method and apparatus for operating a microprocessor in synchronism with a video signal
CY1398A (en) * 1981-09-04 1987-12-18 Glaxo Group Ltd Pharmaceutical compositions containing non-steroidal anti-inflammatory agents
CA1211374A (en) * 1982-05-14 1986-09-16 Eszter Cholnoky Pharmaceutical compositions containing more active ingredients
US4757060A (en) * 1986-03-04 1988-07-12 Bristol-Myers Company Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 and H2, receptor blockers
GB8625325D0 (en) * 1986-10-22 1986-11-26 Glaxo Group Ltd Chemical compounds
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
DE3874917T2 (de) * 1987-03-09 1993-03-04 Procter & Gamble Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen.
CH679582A5 (de) * 1988-07-18 1992-03-13 Glaxo Group Ltd
NZ235877A (en) * 1989-11-02 1992-09-25 Mcneil Ppc Inc Composition comprising acetaminophen or nsaid and an h 1 or h 2 receptor blocker and/or proton pump inhibitor for treating overindulgence
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions
US5128140A (en) * 1991-01-14 1992-07-07 The Procter & Gamble Company Swallowable pharmaceutical compositions

Also Published As

Publication number Publication date
MY108146A (en) 1996-08-30
EP0550083B1 (de) 1999-03-24
NO924704L (no) 1993-06-07
JPH05246853A (ja) 1993-09-24
IL103978A0 (en) 1993-05-13
GB2262036B (en) 1996-01-03
EP0550083A1 (de) 1993-07-07
KR930009605A (ko) 1993-06-21
LU88196A1 (fr) 1993-08-17
DK0550083T3 (da) 1999-10-11
ATA240692A (de) 1996-02-15
AU2986392A (en) 1993-06-10
FR2684554B1 (fr) 1995-09-08
CZ358092A3 (en) 1993-10-13
ES2130152T3 (es) 1999-07-01
BE1007268A3 (fr) 1995-05-09
MX9207008A (es) 1993-06-01
GR3030426T3 (en) 1999-09-30
IE922866A1 (en) 1993-06-16
NZ245365A (en) 1997-06-24
CA2084568A1 (en) 1993-06-07
AP9200453A0 (en) 1993-01-31
NO924704D0 (no) 1992-12-04
CH685537A5 (fr) 1995-08-15
PH31380A (en) 1998-10-29
FR2684554A1 (fr) 1993-06-11
GB9225174D0 (en) 1993-01-20
US5466436A (en) 1995-11-14
GB2262036A (en) 1993-06-09
AU664574B2 (en) 1995-11-23
ITRM920869A1 (it) 1994-06-04
IT1256697B (it) 1995-12-12
AT401468B (de) 1996-09-25
ITRM920869A0 (it) 1992-12-04
IL103978A (en) 1998-06-15
AP324A (en) 1994-03-07
NO303670B1 (no) 1998-08-17

Similar Documents

Publication Publication Date Title
DE69228738D1 (de) Zusammensetzungen zur Behandlung von entzündlichen Zuständen oder Analgesie, die Ranitidin Wismuth Citrat und einen NSAID enthalten
DE3852229D1 (de) Metalle der Platingruppe enthaltende Mikrokapsel und Zusammensetzungen, die diese enthalten.
IT9022032A0 (it) L-2'-desossiuridine e composizioni farmaceutiche che le contengono.
DE69210994T2 (de) Nichtazeotropische zusammensetzungen die difluormethan, 1,1,1-trifluorethan undpropan enthalten
MX9202839A (es) 4-aminoquinolinas y composiciones farmaceuticas de las mismas.
IT1144832B (it) Composizione farmaceutica anti acne e antiseborreica comprendente pasta di calce solforata
NO308533B1 (no) Heteroarylaminer, anvendelse derav og farmasøytisk preparat
DE69207114D1 (de) Phenylmethoxyiminoverbindungen und landwirtschaftliche Fungizide, die sie enthalten
NL990010I2 (nl) Ä3HÜ-imidazo-Ä5,1-dÜ-1,2,3,5-tetrazine-4-on derivaten en farmaceutische samenstellingen, die deze d erivaten bevatten.
DE69007831T2 (de) Bioaktives Produkt; Zusammensetzungen und Stoffe, die dieses bioaktive Produkt enthalten.
DZ1559A1 (fr) Compositions pharmaceutiques.
DE69531722D1 (de) Karzinostatische Zusammensetzungen, welche Cis-Oxaliplatin und eine oder mehrere andere verträgliche Karzinostatika enthalten
DE69002533T2 (de) Indan-1,3-dionderivate und herbizide Zusammensetzungen, die diese als aktiven Bestandteil enthalten.
DE68905973D1 (de) Synergistische suessungsmittel-zusammensetzungen, enthaltend chlorodeoxysucrase, und diese enthaltende zusammensetzungen.
IT1083497B (it) Apparecchio per il trattamento continuo di materiali in particolare l'essiccamento e la sterilizzazione di farina vegetale o animale
DE69323134D1 (de) Zusammensetzungen, die Produkte enthalten, die das Zusammenbacken verhindern und Behandlungen mit diesen Zusammensetzungen
DE3667659D1 (de) Substituierte benzolsulfonamide und antiglaukom-zusammensetzungen die sie enthalten.
DE3480706D1 (de) 5-fluoruracilabkoemmlinge sowie medizinische zusammensetzungen die diese enthalten.
IT8421949A0 (it) N'-sostituite e loro impiego come n-(dicloroacetil)-glicinammidi antidoti in erbicidi. n-sostituite ed eventualmente
IT9048066A0 (it) 2- amminotetraline-6, 7-sostituite attive come immunomodulanti e composizioni farmaceutiche che le contengono.
DE58902161D1 (de) Diorganozinn-verbindungen und diese enthaltende mittel mit bakterizider und fungizider wirkung.
ITMI911147A0 (it) Composto ad attivita' terapeutica,sua preparazione e composizioni farmaceutiche che lo contengono
DE58903565D1 (de) 1,2-naphthochinon-2-diazid-sulfonsaeureamide und lichtempfindliche gemische, die diese enthalten.
DE3669497D1 (de) Cycloalkan-1-ol derivate und duftstoff-zusammensetzungen, die diese enthalten.
IT1209323B (it) Sostanza biologicamente attiva, conproprieta'immuno-stimolanti,sua preparazione e medicamenti che la con tengono per aumentare la resistenza verso le infezioni

Legal Events

Date Code Title Description
8332 No legal effect for de